Discover Dotmatics: Medicon
Dotmatics is hosting a meet and greet on April 9, 2024, from 10 a.m. to 2 p.m. at Inspira, Medicon Village in Lund, Sweden, where attendees can learn how over 2 million researchers use Dotmatics' platform and applications to advance pharma R&D and discuss the role of trustworthy, machine-learning-ready data in AI adoption.
Discover Dotmatics at Medicon Science Park
Join us on Tuesday, April 9th at Inspira between 10 a.m. and 2 p.m. for a company meet and greet.
Learn how more than 2 million researchers from the world’s leading pharma R&D organizations and academic institutions use the Dotmatics platform and applications (Prism, SnapGene, Geneious Prime, etc.) to develop new patient treatment solutions.
You will have an opportunity to discuss the importance of trustworthy, machine-learning-ready data as a foundational element for AI adoption within Dotmatics.
Event Details
- Date: Tuesday, April 9, 2024
- Time: 10am - 2pm
- Location: Inspira, Medicon Village, Scheeletorget 1223 63 Lund, Sweden
Related
Dotmatics Acquired by Siemens for $5.1 Billion to Accelerate AI Innovation in Life Sciences
Siemens AG is acquiring Dotmatics for $5.1 billion to integrate Dotmatics’ scientific R&D software with Siemens’ AI-powered Digital Twin technologies, aiming to accelerate innovation in life sciences research and development and enhance Siemens’ AI-driven product lifecycle management portfolio as part of its ONE Tech Company growth strategy.
Meet Dotmatics: Powering Life Sciences Breakthroughs with AI
The International Business Times article highlights how Dotmatics leverages AI-powered software to accelerate research, transform drug discovery, genomics, and data integration, and drive innovation for life sciences organizations across the APAC region.
U.S. News & World Report: How AI is Transforming Medicine and Patient Care
A U.S. News & World Report article highlights how AI-driven platforms like Dotmatics Luma are revolutionizing healthcare and life sciences by enabling scientists to efficiently manage large datasets, accelerate drug discovery, and enhance patient care through real-time data integration and decision-making.
USA Today: How Dotmatics is Powering the AI-Driven Future of Drug Discovery
The USA Today article highlights Dotmatics as a pivotal force in the AI-driven transformation of drug discovery, emphasizing its cloud-based data management platform and the launch of Luma, a multimodal drug discovery platform that enhances scientific innovation and R&D efficiency.
Trends and Needs in Chemicals and Materials Innovation
Dotmatics’ VP Alister Campbell highlights that despite diverse products, Chemicals and Materials R&D teams face common challenges like regulatory pressures, tight timelines, and budgets, necessitating digitalization strategies focused on quality data management and interoperability to streamline workflows, foster collaboration, and enable AI and machine learning applications that accelerate innovation and maintain competitiveness in this evolving market.
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.